- Home
- ISPR vs PRE Comparison
ISPR vs PRE Comparison
Compare ISPR & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- PRE
- Stock Information
- Founded
- ISPR 2010
- PRE 2014
- Country
- ISPR United States
- PRE Hong Kong
- Employees
- ISPR N/A
- PRE N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ISPR Health Care
- PRE Industrials
- Exchange
- ISPR Nasdaq
- PRE Nasdaq
- Market Cap
- ISPR 126.0M
- PRE 131.3M
- IPO Year
- ISPR 2023
- PRE N/A
- Fundamental
- Price
- ISPR $2.40
- PRE $13.82
- Analyst Decision
- ISPR Strong Buy
- PRE Buy
- Analyst Count
- ISPR 1
- PRE 1
- Target Price
- ISPR $7.50
- PRE $32.00
- AVG Volume (30 Days)
- ISPR 45.3K
- PRE 175.7K
- Earning Date
- ISPR 11-12-2025
- PRE 11-26-2025
- Dividend Yield
- ISPR N/A
- PRE N/A
- EPS Growth
- ISPR N/A
- PRE N/A
- EPS
- ISPR N/A
- PRE N/A
- Revenue
- ISPR $127,494,304.00
- PRE $57,051,000.00
- Revenue This Year
- ISPR $60.96
- PRE $202.46
- Revenue Next Year
- ISPR $23.96
- PRE $103.60
- P/E Ratio
- ISPR N/A
- PRE N/A
- Revenue Growth
- ISPR N/A
- PRE 256.82
- 52 Week Low
- ISPR $2.06
- PRE $3.10
- 52 Week High
- ISPR $7.47
- PRE $17.99
- Technical
- Relative Strength Index (RSI)
- ISPR 41.40
- PRE 48.41
- Support Level
- ISPR $2.10
- PRE $12.05
- Resistance Level
- ISPR $2.32
- PRE $14.18
- Average True Range (ATR)
- ISPR 0.17
- PRE 1.46
- MACD
- ISPR -0.00
- PRE -0.47
- Stochastic Oscillator
- ISPR 27.53
- PRE 25.22
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.